TUTIVIA
LIVE

Serial Number

97590460

Owner

Verici DX Plc

Attorney

Susan Piascik Christoff

Filing Date

Sep 14, 2022

Add to watchlist:

No watchlists yet
View on USPTO

TUTIVIA Trademark

Serial Number: 97590460

TUTIVIA is a trademark filed by Verici DX Plc on September 14, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Verici DX Plc (5 trademarks)

Avon House, 19 Stanwell Road, Parnath
Cardiff CF642EZ , GB

Entity Type: 16

Trademark Details

Filing Date

September 14, 2022

Registration Date

Not Registered

Published for Opposition

August 1, 2023

Goods & Services

Development of new technology for others in the field of medical devices and medical diagnostic apparatuses; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of organ transplant; medical research services; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis

Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; medical analysis services for predicting and identifying risk of graft rejection in organ transplant patients; medical analysis services in the field of organ transplants and organ response

Blood test collection kit comprised of blood collection tube and bag, and holder for medical sample tubes, for predicting and identifying the risk of graft injury and graft loss in organ transplant recipients

Medical diagnostic blood or biopsy testing reagents and assays for advanced next-generation sequencing science for creating immune profiling of organ transplant recipients for predicting and identifying risk of graft rejection; medical diagnostic reagents consisting primarily of reagents for use in disease testing and prediction; nucleic acid sequences and chemical reagents for medical purposes

Filing History

TEAS STATEMENT OF USE RECEIVED
Mar 24, 2026 EISU
SOU TEAS EXTENSION RECEIVED
Mar 24, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 26, 2025 EXRA
SOU EXTENSION 4 GRANTED
Sep 25, 2025 EX4G
SOU EXTENSION 4 FILED
Sep 25, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 25, 2025 EEXT
ASSIGNED TO EXAMINER
Apr 2, 2025 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 12, 2025 EXRA
SOU EXTENSION 3 GRANTED
Mar 12, 2025 EX3G
SOU EXTENSION 3 FILED
Mar 11, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 11, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 25, 2024 EXRA
SOU EXTENSION 2 GRANTED
Sep 25, 2024 EX2G
SOU EXTENSION 2 FILED
Sep 25, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 25, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 26, 2024 EXRA
SOU EXTENSION 1 GRANTED
Mar 25, 2024 EX1G
SOU EXTENSION 1 FILED
Mar 25, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 25, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 26, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 1, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 1, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 12, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 27, 2023 CNSA
ASSIGNED TO EXAMINER
Jun 26, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 29, 2022 NWOS
NEW APPLICATION ENTERED
Sep 17, 2022 NWAP